James Peyer is the CEO and Founder of Cambrian. Peyer's goal with his pharma-bio company is to create healthier drugs that lengthen lifespans and improve overall health in individuals. Peyer was previously Managing Partner with Apollo Ventures, the first global longevity-focused venture capital firm. He is a graduate of UT Southwestern (National Science Foundation Fellow) with a PhD in blood and stem cell biology.

James and Diane Brady speak at Founder's Forum about Cambrian's newest business developments, timelines of producing Cambrian's products and how a healthier lifestyle holds as much influence as good medicine.

Stay Connected

Forbes newsletters: https://newsletters.editorial.forbes.com

Forbes on Facebook: http://fb.com/forbes

Forbes Video on Twitter: http://www.twitter.com/forbes

Forbes Video on Instagram: http://instagram.com/forbes

More From Forbes: http://forbes.com

Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This Pharma Exec Has A New Treatment To Extend Life, Plus A Possible Landmark Weight-Loss Drug